GlassScriptPhysician profile
Randel Lavelle Smith
NPI 1639288293
$3,137.33
in general payments reported to CMS, 2019-2025
23 companies · $814 in 2025
The $814 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $200 · 2021: $466 · 2022: $405 · 2023: $92.39 · 2024: $757 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,663.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $671.19 | 2019-2025 | |
| Medtronic, INC. | $595.32 | 2024-2025 | Corevalve Evolut R, Micra, Cobalt Dr Mri Surescan |
| Abiomed | $378.79 | 2019-2024 | Impella |
| Boston Scientific Corporation | $280.93 | 2019-2024 | Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $165.65 | 2020-2025 | Lifevest |
| Philips North America LLC | $158.20 | 2019-2025 | Ecc Solutions, Coronary Undivided |
| Lexicon Pharmaceuticals, INC. | $136.91 | 2024 | Inpefa |
| Abbott Laboratories | $116.87 | 2019-2024 | Mitraclip |
| Chiesi USA, INC. | $116.14 | 2020-2021 | |
| Shockwave Medical, INC | $111.08 | 2025 | |
| Scpharmaceuticals INC. | $92.39 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $67.47 | 2025 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $50.27 | 2025 | |
| Pfizer INC. | $41.82 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.38 | 2025 | Jardiance |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $29.00 | 2019 | |
| Impulse Dynamics (USA) INC. | $24.66 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.24 | 2025 | Eliquis |
| Siemens Medical Solutions USA, INC. | $19.64 | 2024 | Acuson Origin Diagnostic Ultrasound System |
| Alnylam Pharmaceuticals INC. | $15.10 | 2025 | Onpattro |
| Medtronic Vascular, INC. | $13.28 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randel Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.